Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cellectar Biosciences, Inc. CLRB

Full chart Compare
Set alert

Price alert · CLRB

All alert types
1.30 USD +0.07 (+6.15%)

Nov 3, 2026, 3:32 PM EST

1.23 Day range 1.31
1.12 52-week range 4.70
YTD
-56.10%
1 year
-60.76%

Financial health

Altman Z-Score

-10.78 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.4×
FY 2016: -0.6×FY 2017: -1.3×FY 2018: -0.3×FY 2019: -1.2×FY 2020: -2.7×FY 2021: -1.5×FY 2022: -0.4×FY 2023: -0.8×FY 2024: -0.2×FY 2025: -0.4×
FY 2016 5y median -0.4× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.8×
FY 2016: 0.4×FY 2017: 1.8×FY 2018: 0.3×FY 2019: 1.9×FY 2020: 0.8×FY 2021: 1.1×FY 2022: 1.3×FY 2023: -2.5×FY 2024: 0.8×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
P/FCF -0.3×
FY 2016: -0.6×FY 2017: -1.7×FY 2018: -0.4×FY 2019: -1.5×FY 2020: -2.9×FY 2021: -1.6×FY 2022: -0.5×FY 2023: -1.0×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.5× FY 2025
EV/EBITDA 0.2×
FY 2016: 0.7×FY 2017: -0.8×FY 2018: 0.7×FY 2019: -0.5×FY 2020: 1.0×FY 2021: -0.1×FY 2022: 0.2×FY 2023: -0.6×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -300.5%
FY 2016: -156.9%FY 2017: -59.1%FY 2018: -257.6%FY 2019: -67.9%FY 2020: -34.0%FY 2021: -62.0%FY 2022: -210.9%FY 2023: -98.2%FY 2024: -435.5%FY 2025: -300.5%
FY 2016 5y median -210.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -219.7%
FY 2016: -45.6%FY 2017: -126.1%FY 2018: -99.8%FY 2019: -155.6%FY 2020: -27.5%FY 2021: -73.0%FY 2022: -333.4%FY 2023: 310.5%FY 2024: -311.9%FY 2025: -219.7%
FY 2016 5y median -219.7% FY 2025
ROIC -222.5%
FY 2016: -68.6%FY 2017: -132.1%FY 2018: -99.2%FY 2019: -147.9%FY 2020: -27.7%FY 2021: -72.4%FY 2022: -283.6%FY 2023: 294.2%FY 2024: -320.2%FY 2025: -222.5%
FY 2016 5y median -222.5% FY 2025
ROA -145.5%
FY 2016: -40.3%FY 2017: -105.4%FY 2018: -87.9%FY 2019: -115.0%FY 2020: -25.7%FY 2021: -64.8%FY 2022: -147.3%FY 2023: -354.2%FY 2024: -175.0%FY 2025: -145.5%
FY 2016 5y median -147.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 55.6%
FY 2016: -7.9%FY 2017: -43.9%FY 2018: 2.0%FY 2019: -6.4%FY 2020: -7.8%FY 2021: -57.8%FY 2022: -19.4%FY 2023: -35.2%FY 2024: -32.9%FY 2025: 55.6%
FY 2016 FY 2025
EPS (diluted) 80.1%
FY 2016: 69.6%FY 2017: 50.0%FY 2018: 51.2%FY 2019: 64.9%FY 2020: 58.5%FY 2021: 43.0%FY 2022: -3.7%FY 2023: 22.3%FY 2024: 60.1%FY 2025: 80.1%
FY 2016 FY 2025
Free Cash Flow 51.5%
FY 2016: -1.0%FY 2017: -36.1%FY 2018: -4.0%FY 2019: 0.9%FY 2020: -19.4%FY 2021: -62.3%FY 2022: -12.1%FY 2023: -30.6%FY 2024: -43.5%FY 2025: 51.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.0×
FY 2016: 7.5×FY 2017: 5.0×FY 2018: 8.6×FY 2019: 4.1×FY 2020: 16.3×FY 2021: 9.2×FY 2022: 1.8×FY 2023: 0.4×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 3.0×
FY 2016: 7.5×FY 2017: 5.0×FY 2018: 8.6×FY 2019: 4.1×FY 2020: 16.3×FY 2021: 9.2×FY 2022: 1.8×FY 2023: 0.4×FY 2024: 2.6×FY 2025: 3.0×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2016: 1.2×FY 2017: 0.8×FY 2018: 1.0×FY 2019: 0.7×FY 2020: 3.8×FY 2021: 1.5×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.5×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: -1197×FY 2017: -819×FY 2018: -449×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31